Use of Semaglutide acetate salt:
Semaglutide, a long-acting GLP-1 analogue, is a glucagon-like peptide-1 (GLP-1) receptor agonist that can be used in the treatment of type 2 diabetes.
*The following content is generated by AI and is for reference only.
<h3>Overview</h3>
<p>Semaglutide is a <strong>GLP-1 receptor agonist</strong> synthesized via solid-phase peptide synthesis. Its molecular formula is <strong>C31H48N6O5</strong> with CAS No. 910463-68-2.</p>
<h3>Application</h3>
<ul>
<li><strong>Pharmaceutical Manufacturing:</strong> Production of injectable formulations for Type 2 Diabetes management.</li>
<li><strong>Obesity Treatment:</strong> Development of weight loss therapies under strict regulatory frameworks.</li>
<li><strong>Research & Development:</strong> Use in clinical trials for cardiovascular outcome studies.</li>
</ul>
<h3>Precautions</h3>
<p>Strictly contraindicated for patients with personal or family history of medullary thyroid carcinoma. Store at controlled room temperature (20°C–25°C) and protect from light to maintain stability.</p>